Clinical Trial

Chicago Data-driven Opioid Use Disorder Screening, Engagement, Treatment and Planning System

Study acronym: C-DOSETaP
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study, called the Chicago Data-driven Opioid use disorder Screening, Engagement, Treatment and Planning (C-DOSETaP) System, tests a new system of clinical care for patients with opioid use disorder (OUD) across a large health system. The main questions this study aims to answer are: 1. Does the C-DOSETaP System increase screening for patients with OUD; 2. Does the C-DOSETaP System improve continuity of health care for patients with OUD; 3. Does the C-DOSETaP System increase use of medications for opioid use disorder; and 4. Does the C-DOSETaP System reduce the number of opioid-related deaths in the neighborhoods served.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-23.
Trial Details
NCT Number NCT07498322
Lead Sponsor University of Illinois at Chicago
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions Opiod Use Disorder
Enrollment 271,031 participants
Start Date 2026-06-01
Primary Completion 2028-12-31 (estimated)
Study Completion 2029-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-01